This alteration hinders the movement of T cells, particularly CD8+ T cells, creating a barrier effect against the infiltration of drugs and immune cells and ultimately leading to the suppression of anti-tumor immunity (García-Palmero et al., 2016; Zhang et al., 2016). This evidence concerns the gene CD8A and neoplasm.